Crinetics Pharmaceuticals, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $4.28M, a 48.65% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $2.34M, a 6.46% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $2.88M, a 42.08% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $5.22M, a 23.56% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $4.22M, a 84.37% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $2.29M, a 41.59% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.62M, a 58.47% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $4.28M 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.22M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $2.88M 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.22M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $2.03M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.29M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $1.12M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $805.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.62M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | |
| 2022-06-30 | $813.00K 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.02M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2021-06-30 | $522.00K 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $691.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $7.19M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | $407.00K 10-Q · filed 2021-08-10 | $7.19M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | $6.43M 10-Q · filed 2020-05-08 | $7.16M derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | $356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $735.00K 10-K · filed 2022-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-06-30 | $379.00K 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $282.00K 10-K · filed 2021-03-30 |